Plain-English translation of NCT06539793 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a treatment called non-invasive neuromodulation—a procedure that gently stimulates nerves without surgery—combined with exercise to help reduce fibromyalgia pain. Researchers want to see if this approach can help ease symptoms and improve your quality of life. Half of the participants will receive real neuromodulation, and half will receive a placebo version (a sham treatment) to see what difference the real treatment makes.
Fibromyalgia causes widespread pain and can severely limit daily activities, and current treatments don't work well for everyone. This trial aims to find out whether non-invasive neuromodulation might be an effective new option to help people manage their pain and function better.
You likely qualify if…
You likely don't qualify if…
You will come to the clinic 3 times per week for 4 weeks, with each visit lasting about one hour. Every visit will include exercise therapy. Depending on which group you're randomly assigned to, you will also receive either real non-invasive brain stimulation or a placebo version. Researchers will measure your pain levels and how well you're functioning before, during, and after the 4-week program to see if the treatment helps.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Egypt
Sponsor
Ahmed Alshimy
Enrollment target
~40 participants
Started
September 2024
Primary completion
April 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
25 Years – 35 Years
Last updated on clinicaltrials.gov in August 2024.
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.